ConductScience.org, home

Paper42657117

Glycolytic reprogramming in precancerous lesions of gastric cancer progression: pathogenesis and therapeutic potential.

Niu S and 6 others. Front Oncol, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Glycolytic reprogramming in precancerous lesions of gastric cancer progression: pathogenesis and therapeutic potential. Papers, record 42657117. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42657117

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Glycolytic reprogramming in precancerous lesions of gastric cancer progression: pathogenesis and therapeutic potential.
PubMed
Journal
Front Oncol
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-28
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Niu SSiying
2Sun HHeyuan
3Wang ZZijian
4Jin QQiuyu
5Sun ZZhiwen
6Yu DDongyang
7Zhang YYang

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References107

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121862591Inhibition of glycolytic enzymes mediated by pharmacologically activated p53: targeting Warburg effect to fight cancer.J Biol Chem2011https://conductscience.org/library/papers/21862591PubMed
220728210
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.
Lancet2010https://conductscience.org/library/papers/20728210PubMed
337746871Gastric epithelial stem cells in development, homeostasis and regeneration.Development2023https://conductscience.org/library/papers/37746871PubMed
441349881Ditrioxzin synergizes with 2-deoxy-d-glucose to induce redox-dependent metabolic crisis in gastric cancer through dual targeting of peroxiredoxin 3 and glycolysis.Toxicol Appl Pharmacol2026https://conductscience.org/library/papers/41349881PubMed
529108235Regulation of SIRT3 signal related metabolic reprogramming in gastric cancer by Helicobacter pylori oncoprotein CagA.Oncotarget2017https://conductscience.org/library/papers/29108235PubMed
633072570LncRNA-BLACAT1 Facilitates Proliferation, Migration and Aerobic Glycolysis of Pancreatic Cancer Cells by Repressing CDKN1C via EZH2-Induced H3K27me3.Front Oncol2020https://conductscience.org/library/papers/33072570PubMed
737081005Helicobacter pylori infection.Nat Rev Dis Primers2023https://conductscience.org/library/papers/37081005PubMed
837009319Xiaojianzhong decoction prevents gastric precancerous lesions in rats by inhibiting autophagy and glycolysis in gastric mucosal cells.World J Gastrointest Oncol2023https://conductscience.org/library/papers/37009319PubMed
938335913(-)-Asarinin alleviates gastric precancerous lesions by promoting mitochondrial ROS accumulation and inhibiting the STAT3 signaling pathway.Phytomedicine2024https://conductscience.org/library/papers/38335913PubMed
1024162660Building blocks of the apoptotic pore: how Bax and Bak are activated and oligomerize during apoptosis.Cell Death Differ2014https://conductscience.org/library/papers/24162660PubMed
1139719478The plasticity of epithelial cells and its potential in the induced differentiation of gastric cancer.Cell Death Discov2024https://conductscience.org/library/papers/39719478PubMed
1226771115The Emerging Hallmarks of Cancer Metabolism.Cell Metab2016https://conductscience.org/library/papers/26771115PubMed
1336050306Lactate metabolism in human health and disease.Signal Transduct Target Ther2022https://conductscience.org/library/papers/36050306PubMed
1431648165Protective effects of Weipixiao decoction against MNNG-induced gastric precancerous lesions in rats.Biomed Pharmacother2019https://conductscience.org/library/papers/31648165PubMed
1539966374Energy metabolism in health and diseases.Signal Transduct Target Ther2025https://conductscience.org/library/papers/39966374PubMed
1638130998Thioridazine reverses trastuzumab resistance in gastric cancer by inhibiting S-phase kinase associated protein 2-mediated aerobic glycolysis.World J Gastroenterol2023https://conductscience.org/library/papers/38130998PubMed
1739603037Modified Zuojin pill alleviates gastric precancerous lesions by inhibiting glycolysis through the HIF-1α pathway.Phytomedicine2025https://conductscience.org/library/papers/39603037PubMed
1840311713Research progress on the regulatory role of lactate and lactylation in tumor microenvironment.Biochim Biophys Acta Rev Cancer2025https://conductscience.org/library/papers/40311713PubMed
1932753880Helicobacter pylori CagA Protein Attenuates 5-Fu Sensitivity of Gastric Cancer Cells Through Upregulating Cellular Glucose Metabolism.Onco Targets Ther2020https://conductscience.org/library/papers/32753880PubMed
2037117116The Warburg effect: a signature of mitochondrial overload.Trends Cell Biol2023https://conductscience.org/library/papers/37117116PubMed

See all 107 referencesDownload CSV of references

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42657117

GET https://conductscience.org/api/papers/v1/42657117/references?page=2